Chinese Cephalexin Market Stable in Early November After October 0.4% Gain, Slight Decline Expected

The Chinese Cephalexin market was stable in the first half of November after a small upsurge in October. Producers at key facilities kept running without interruption and there was a steady supply of Cephalexin for domestic and export demand. The stability was supported by balanced inventory at major hubs including Shanghai, so manufacturers and distributors were not in a rush. Despite pharmaceutical export inquiries across Asia-Pacific, buying sentiment was cautious as importers monitored inventory and seasonal demand trends. Feedstock costs  were steady, so production cost was predictable and Cephalexin price was stable. Logistics and port operation was smooth and Cephalexin market was in equilibrium.

In October ****, Cephalexin (USP) FOB Shanghai increased *.** to USD **,***/MT. This was due to post-Golden Week restocking, pharmaceutical export orders and production back to normal after the holiday. Capacity utilization went back to normal, and...